Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (48)
Yanshu Liang, Shuang Zhi, Zhixia Qiao & Fancui Meng. (2022) Molecular dynamics simulations of a central nervous system-penetrant drug AZD3759 with lipid bilayer. Journal of Molecular Modeling 28:9.
Crossref
Crossref
Kristiina M. Huttunen, Tetsuya Terasaki, Arto Urtti, Ahmed B. Montaser & Yasuo Uchida. (2022) Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery. Pharmaceutical Research 39:7, pages 1363-1392.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
217
222
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
233
242
.
Sho Sato, Kota Matsumiya, Kimio Tohyama & Yohei Kosugi. (2021) Translational CNS Steady-State Drug Disposition Model in Rats, Monkeys, and Humans for Quantitative Prediction of Brain-to-Plasma and Cerebrospinal Fluid-to-Plasma Unbound Concentration Ratios. The AAPS Journal 23:4.
Crossref
Crossref
Heinrich Rueeger, Rainer Lueoend, Rainer Machauer, Siem J. Veenstra, Philipp Holzer, Konstanze Hurth, Markus Voegtle, Mathias Frederiksen, Jean-Michel Rondeau, Marina Tintelnot-Blomley, Laura H. Jacobson, Matthias Staufenbiel, Grit Laue & Ulf Neumann. (2021) Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360. Journal of Medicinal Chemistry 64:8, pages 4677-4696.
Crossref
Crossref
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
6
.
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
10
.
Sukanthini Thurairatnam, Sungtaek Lim, Robert H. BarkerJr.Jr., Yong Mi Choi-Sledeski, Bradford H. Hirth, John Jiang, John E. Macor, Elina Makino, Sachin Maniar, Kwon Musick, James R. Pribish & Mark Munson. (2020) Brain Penetrable Inhibitors of Ceramide Galactosyltransferase for the Treatment of Lysosomal Storage Disorders. ACS Medicinal Chemistry Letters 11:10, pages 2010-2016.
Crossref
Crossref
Paolo Becco, Susanna Gallo, Stefano Poletto, Mirko Pio Manlio Frascione, Luca Crotto, Alessandro Zaccagna, Luca Paruzzo, Daniela Caravelli, Fabrizio Carnevale-Schianca & Massimo Aglietta. (2020) Melanoma Brain Metastases in the Era of Target Therapies: An Overview. Cancers 12:6, pages 1640.
Crossref
Crossref
Terje Sundstrøm, Lars Prestegarden, Francisco Azuaje, Synnøve Nymark Aasen, Gro Vatne Røsland, Jobin K. Varughese, Marzieh Bahador, Simon Bernatz, Yannick Braun, Patrick N. Harter, Kai Ove Skaftnesmo, Elizabeth S. Ingham, Lisa M. Mahakian, Sarah Tam, Clifford G. Tepper, Kjell Petersen, Katherine W. Ferrara, Karl Johan Tronstad, Morten Lund-Johansen, Rudi Beschorner, Rolf Bjerkvig & Frits Thorsen. (2019) Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis. Acta Neuropathologica Communications 7:1.
Crossref
Crossref
Sonali S. Bharate, Serge Mignani & Ram A. Vishwakarma. (2018) Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis. Journal of Medicinal Chemistry 61:23, pages 10345-10374.
Crossref
Crossref
Ying Wang, Hongyu Zhao, Jason T. Brewer, Huanqiu Li, Yanbin Lao, Willi Amberg, Berthold Behl, Irini Akritopoulou-Zanze, Justin Dietrich, Udo E. W. Lange, Frauke Pohlki, Carolin Hoft, Wilfried Hornberger, Stevan W. Djuric, Jens Sydor, Mario Mezler, Ana Lucia Relo & Anil Vasudevan. (2018) De Novo Design, Synthesis, and Biological Evaluation of 3,4-Disubstituted Pyrrolidine Sulfonamides as Potent and Selective Glycine Transporter 1 Competitive Inhibitors. Journal of Medicinal Chemistry 61:17, pages 7486-7502.
Crossref
Crossref
Kasper Fjelbye, Mauro Marigo, Rasmus P. Clausen, Erling B. Jørgensen, Claus T. Christoffersen & Karsten Juhl. (2018)
Elucidation of fluorine's impact on p
K
a
and
in vitro
Pgp-mediated efflux for a series of PDE9 inhibitors
. MedChemComm 9:5, pages 893-896.
Crossref
Crossref
Leonardo B. de Paula, Fernando L. Primo & Antonio C. Tedesco. (2017) Nanomedicine associated with photodynamic therapy for glioblastoma treatment. Biophysical Reviews 9:5, pages 761-773.
Crossref
Crossref
Mark C. Field, David Horn, Alan H. Fairlamb, Michael A. J. Ferguson, David W. Gray, Kevin D. Read, Manu De Rycker, Leah S. Torrie, Paul G. Wyatt, Susan Wyllie & Ian H. Gilbert. (2017) Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nature Reviews Microbiology 15:4, pages 217-231.
Crossref
Crossref
Z. Ates-Alagoz & A. Adejare. 2017. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders
59
82
.
M.C. Noe & M.-C. Peakman. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
1
32
.
George Lambrinidis, Fotios Tsopelas, Costas Giaginis & Anna Tsantili-Kakoulidou. 2017. Advances in QSAR Modeling. Advances in QSAR Modeling
339
384
.
Cyrille Lescop, Claus Müller, Boris Mathys, Magdalena Birker, Ruben de Kanter, Christopher Kohl, Patrick Hess, Oliver Nayler, Markus Rey, Patrick Sieber, Beat Steiner, Thomas Weller & Martin H. Bolli. (2016) Novel S1P 1 receptor agonists – Part 4: Alkylaminomethyl substituted aryl head groups. European Journal of Medicinal Chemistry 116, pages 222-238.
Crossref
Crossref
Kevin M. Gardinier, Douglas L. Gernert, Warren J. Porter, Jon K. Reel, Paul L. Ornstein, Patrick Spinazze, F. Craig Stevens, Patric Hahn, Sean P. Hollinshead, Daniel Mayhugh, Jeff Schkeryantz, Albert Khilevich, Oscar De Frutos, Scott D. Gleason, Akihiko S. Kato, Debra Luffer-Atlas, Prashant V. Desai, Steven Swanson, Kevin D. Burris, Chunjin Ding, Beverly A. Heinz, Anne B. Need, Vanessa N. Barth, Gregory A. Stephenson, Benjamin A. Diseroad, Tim A. Woods, Hong Yu, David Bredt & Jeffrey M. Witkin. (2016) Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8. Journal of Medicinal Chemistry 59:10, pages 4753-4768.
Crossref
Crossref
Yan-Yan Zhang, Houfu Liu, Scott G. SummerfieldChristopher N. LuscombeJasminder Sahi. (2016)
Integrating
in Silico
and
in Vitro
Approaches To Predict Drug Accessibility to the Central Nervous System
. Molecular Pharmaceutics 13:5, pages 1540-1550.
Crossref
Crossref
Heike Seifert, Eishu Hirata, Martin Gore, Komel Khabra, Christina Messiou, James Larkin & Erik Sahai. (2015)
Extrinsic factors can mediate resistance to
BRAF
inhibition in central nervous system melanoma metastases
. Pigment Cell & Melanoma Research 29:1, pages 92-100.
Crossref
Crossref
Matthew C.T. Fyfe. 2016.
1
44
.
Andrew Woodland, Stephen Thompson, Laura A. T. Cleghorn, Neil Norcross, Manu De Rycker, Raffaella Grimaldi, Irene Hallyburton, Bhavya Rao, Suzanne Norval, Laste Stojanovski, Reto Brun, Marcel Kaiser, Julie A. Frearson, David W. Gray, Paul G. Wyatt, Kevin D. Read & Ian H. Gilbert. (2015)
Discovery of Inhibitors of
Trypanosoma brucei
by Phenotypic Screening of a Focused Protein Kinase Library
. ChemMedChem 10:11, pages 1809-1820.
Crossref
Crossref
Qingbei Zeng, Jiabing Wang, Ziqiang Cheng, Kan Chen, Peter Johnström, Katarina Varnäs, David Yunzhi Li, Zhen Fan Yang & Xiaolin Zhang. (2015) Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Journal of Medicinal Chemistry 58:20, pages 8200-8215.
Crossref
Crossref
Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepcion Sanchez-Martinez & Alfonso De Dios. (2015) Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft. Drug Metabolism and Disposition 43:9, pages 1360-1371.
Crossref
Crossref
Chudi O. Ndubaku, Terry D. Crawford, Huifen Chen, Jason W. Boggs, Joy Drobnick, Seth F. Harris, Rajiv Jesudason, Erin McNamara, Jim Nonomiya, Amy Sambrone, Stephen Schmidt, Tanya Smyczek, Philip Vitorino, Lan Wang, Ping Wu, Stacey Yeung, Jinhua Chen, Kevin Chen, Charles Z. Ding, Tao Wang, Zijin Xu, Stephen E. Gould, Lesley J. Murray & Weilan Ye. (2015) Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis. ACS Medicinal Chemistry Letters 6:8, pages 913-918.
Crossref
Crossref
Christopher L. Shaffer, Nandini C. Patel, Jacob Schwarz, Renato J. Scialis, Yunjing Wei, Xinjun J. Hou, Longfei Xie, Kapil Karki, Dianne K. Bryce, Sarah M. Osgood, William E. Hoffmann, John T. Lazzaro, Cheng Chang, Dina F. McGinnis, Susan M. Lotarski, JianHua Liu, R. Scott Obach, Mark L. Weber, Laigao Chen, Kenneth R. Zasadny, Patricia A. Seymour, Christopher J. Schmidt, Mihály Hajós, Raymond S. Hurst, Jayvardhan Pandit & Christopher J. O’Donnell. (2015)
The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator
N
-{(3
S
,4
S
)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)
. Journal of Medicinal Chemistry 58:10, pages 4291-4308.
Crossref
Crossref
Kevin J. Hodgetts. 2015. Blood-Brain Barrier in Drug Discovery. Blood-Brain Barrier in Drug Discovery
425
445
.
Martin H. Bolli, Stefan Abele, Magdalena Birker, Roberto Bravo, Daniel Bur, Ruben de Kanter, Christopher Kohl, Julien Grimont, Patrick Hess, Cyrille Lescop, Boris Mathys, Claus Müller, Oliver Nayler, Markus Rey, Michael Scherz, Gunther Schmidt, Jürgen Seifert, Beat Steiner, Jörg Velker & Thomas Weller. (2013)
Novel S1P
1
Receptor Agonists − Part 3: From Thiophenes to Pyridines
. Journal of Medicinal Chemistry 57:1, pages 110-130.
Crossref
Crossref
Linjing Mu & Simon M. Ametamey. 2014. PET and SPECT of Neurobiological Systems. PET and SPECT of Neurobiological Systems
409
443
.
Jack Murrell & Ruth Board. (2013) The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: Opportunities and unanswered questions. Cancer Treatment Reviews 39:8, pages 833-838.
Crossref
Crossref
David M. Wilson, James Apps, Nicholas Bailey, Mark J. Bamford, Isabel J. Beresford, Kim Brackenborough, Michael A. Briggs, Stephen Brough, Andrew R. Calver, Barry Crook, Rebecca K. Davis, Robert P. Davis, Susannah Davis, David K. Dean, Leanne Harris, Teresa Heslop, Vicky Holland, Phillip Jeffrey, Terrance A. Panchal, Christopher A. Parr, Nigel Quashie, Joanne Schogger, Sanjeet S. Sehmi, Tania O. Stean, Jon G.A. Steadman, Brenda Trail, Jeffrey Wald, Angela Worby, Andrew K. Takle, Jason Witherington & Andrew D. Medhurst. (2013) Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 23:24, pages 6890-6896.
Crossref
Crossref
David M. Wilson, James Apps, Nicholas Bailey, Mark J. Bamford, Isabel J. Beresford, Michael A. Briggs, Andrew R. Calver, Barry Crook, Robert P. Davis, Susannah Davis, David K. Dean, Leanne Harris, Tom D. Heightman, Terry Panchal, Christopher A. Parr, Nigel Quashie, Jon G.A. Steadman, Joanne Schogger, Sanjeet S. Sehmi, Tania O. Stean, Andrew K. Takle, Brenda K. Trail, Trevor White, Jason Witherington, Angela Worby & Andrew D. Medhurst. (2013) The discovery of the benzazepine class of histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 23:24, pages 6897-6901.
Crossref
Crossref
Tjerk Bueters, Bart A. Ploeger & Sandra A.G. Visser. (2013) The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives. Drug Discovery Today 18:17-18, pages 853-862.
Crossref
Crossref
Amy B. Dounay, Marie Anderson, Bruce M. Bechle, Edelweiss Evrard, Xinmin Gan, Ji-Young Kim, Laura A. McAllister, Jayvardhan Pandit, SuoBao Rong, Michelle A. Salafia, Jamison B. Tuttle, Laura E. Zawadzke & Patrick R. Verhoest. (2013) PF-04859989 as a template for structure-based drug design: Identification of new pyrazole series of irreversible KAT II inhibitors with improved lipophilic efficiency. Bioorganic & Medicinal Chemistry Letters 23:7, pages 1961-1966.
Crossref
Crossref
MELISA GUALDRÓN-LÓPEZ, ANA BRENNAND, LUISANA AVILÁN & PAUL A. M. MICHELS. (2012) Translocation of solutes and proteins across the glycosomal membrane of trypanosomes; possibilities and limitations for targeting with trypanocidal drugs. Parasitology 140:1, pages 1-20.
Crossref
Crossref
Andrew W. Stamford, Jack D. Scott, Sarah W. Li, Suresh Babu, Dawit Tadesse, Rachael Hunter, Yusheng Wu, Jeffrey Misiaszek, Jared N. Cumming, Eric J. Gilbert, Chunli Huang, Brian A. McKittrick, Liwu Hong, Tao Guo, Zhaoning Zhu, Corey Strickland, Peter Orth, Johannes H. Voigt, Matthew E. Kennedy, Xia Chen, Reshma Kuvelkar, Robert Hodgson, Lynn A. Hyde, Kathleen Cox, Leonard Favreau, Eric M. Parker & William J. Greenlee. (2012) Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction. ACS Medicinal Chemistry Letters 3:11, pages 897-902.
Crossref
Crossref
Hongbing Huang, Daniel S. La, Alan C. Cheng, Douglas A. Whittington, Vinod F. Patel, Kui Chen, Thomas A. Dineen, Oleg Epstein, Russell Graceffa, Dean Hickman, Y.-H. Kiang, Steven Louie, Yi Luo, Robert C. Wahl, Paul H. Wen, Stephen Wood & Robert T. FremeauJr.Jr.. (2012) Structure- and Property-Based Design of Aminooxazoline Xanthenes as Selective, Orally Efficacious, and CNS Penetrable BACE Inhibitors for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry 55:21, pages 9156-9169.
Crossref
Crossref
Prashant V. Desai, Thomas J. Raub & Maria-Jesus Blanco. (2012) How hydrogen bonds impact P-glycoprotein transport and permeability. Bioorganic & Medicinal Chemistry Letters 22:21, pages 6540-6548.
Crossref
Crossref
Alexander V. LyubimovHaojing Rong, Bo Feng & Li Di. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
28
.
Stephen A. Hitchcock. (2012) Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds. Journal of Medicinal Chemistry 55:11, pages 4877-4895.
Crossref
Crossref
Heinrich Rueeger, Rainer Lueoend, Olivier Rogel, Jean-Michel Rondeau, Henrik Möbitz, Rainer Machauer, Laura Jacobson, Matthias Staufenbiel, Sandrine Desrayaud & Ulf Neumann. (2012) Discovery of Cyclic Sulfone Hydroxyethylamines as Potent and Selective β-Site APP-Cleaving Enzyme 1 (BACE1) Inhibitors: Structure-Based Design and in Vivo Reduction of Amyloid β-Peptides. Journal of Medicinal Chemistry 55:7, pages 3364-3386.
Crossref
Crossref
Christoffer Bundgaard, Christian Jes Nyberg Jensen & Mats Garmer. (2012)
Species Comparison of In Vivo P-Glycoprotein-Mediated Brain Efflux Using
mdr1a
-Deficient Rats and Mice
. Drug Metabolism and Disposition 40:3, pages 461-466.
Crossref
Crossref
Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins, Bruce D. Dorsey & John P. Mallamo. (2011) Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chemical Neuroscience 3:1, pages 50-68.
Crossref
Crossref
Frank E. Koehn. (2012) Biosynthetic medicinal chemistry of natural product drugs. MedChemComm 3:8, pages 854.
Crossref
Crossref
Emmanuel H. Demont, Sandra Arpino, Rino A. Bit, Colin A. Campbell, Nigel Deeks, Sapna Desai, Simon J. Dowell, Pam Gaskin, James R. J. Gray, Lee A. Harrison, Andrea Haynes, Tom D. Heightman, Duncan S. Holmes, Philip G. Humphreys, Umesh Kumar, Mary A. Morse, Greg J. Osborne, Terry Panchal, Karen L. Philpott, Simon Taylor, Robert Watson, Robert Willis & Jason Witherington. (2011)
Discovery of a Brain-Penetrant S1P
3
-Sparing Direct Agonist of the S1P
1
and S1P
5
Receptors Efficacious at Low Oral Dose
. Journal of Medicinal Chemistry 54:19, pages 6724-6733.
Crossref
Crossref